Screener
BioSig Technologies, Inc. STEX Total Revenue
Discontinued — last reported Q2 '26
Total Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: BioSig Technologies, Inc.’s 10-Q, filed August 14, 2026.
- Filed
- Aug 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001493152-26-038293
| Line item | 2026 / For the Three Months Ended June 30, | 2025 / For the Three Months Ended June 30, | 2026 / For the Six Months Ended June 30, | 2025 / For the Six Months Ended June 30, |
|---|---|---|---|---|
| Gold lease income | $146 | - | $146 | - |
| Operating expenses: | ||||
| General and administrative | 13,836 | 19,811 | 48,089 | 22,773 |
| Depreciation and amortization | 1,471 | 554 | 2,963 | 577 |
| Total operating expenses | 15,307 | 20,365 | 51,052 | 23,350 |
| Loss from operations | (15,161) | (20,365) | (50,906) | (23,350) |
| Other income (expense): | ||||
| Interest (expense) income, net | (3) | 13 | (12,198) | 13 |
Document
FAQ
- What is BioSig Technologies, Inc.'s total revenue?
- BioSig Technologies, Inc. (STEX) reported total revenue of $146K in Q2 2026.
- What is the long-term trend for BioSig Technologies, Inc.'s total revenue?
- Over 3 years (2021 to 2024), BioSig Technologies, Inc.'s total revenue has grown at a -55.1% compound annual growth rate (CAGR), from $441K to $40K.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about BioSig Technologies, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude